Westlake Chemical Partners LP
WLKP
$23.07
-$0.13-0.56%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.14B | 1.14B | 1.19B | 1.17B | 1.19B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.14B | 1.14B | 1.19B | 1.17B | 1.19B |
| Cost of Revenue | 716.96M | 728.29M | 790.70M | 784.22M | 803.33M |
| Gross Profit | 418.94M | 414.82M | 397.08M | 383.57M | 387.46M |
| SG&A Expenses | 28.50M | 29.80M | 29.29M | 28.91M | 29.75M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 745.45M | 758.10M | 819.99M | 813.14M | 833.08M |
| Operating Income | 390.44M | 385.01M | 367.79M | 354.65M | 357.71M |
| Income Before Tax | 369.99M | 369.67M | 346.43M | 333.63M | 335.44M |
| Income Tax Expenses | 835.00K | 839.00K | 845.00K | 811.00K | 813.00K |
| Earnings from Continuing Operations | 369.16 | 368.83 | 345.58 | 332.82 | 334.63 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -306.77M | -307.13M | -288.82M | -278.60M | -280.34M |
| Net Income | 62.39M | 61.70M | 56.77M | 54.22M | 54.28M |
| EBIT | 390.44M | 385.01M | 367.79M | 354.65M | 357.71M |
| EBITDA | 502.34M | 497.74M | 480.62M | 466.21M | 467.91M |
| EPS Basic | 1.78 | 1.76 | 1.62 | 1.54 | 1.55 |
| Normalized Basic EPS | -2.15 | -2.28 | -2.06 | -1.99 | -2.01 |
| EPS Diluted | 1.78 | 1.76 | 1.62 | 1.54 | 1.55 |
| Normalized Diluted EPS | -2.15 | -2.28 | -2.06 | -1.99 | -2.01 |
| Average Basic Shares Outstanding | 140.57M | 140.57M | 140.56M | 140.55M | 140.54M |
| Average Diluted Shares Outstanding | 140.57M | 140.57M | 140.56M | 140.55M | 140.54M |
| Dividend Per Share | 1.89 | 1.89 | 1.89 | 1.89 | 1.89 |
| Payout Ratio | 106.48% | 107.68% | 117.02% | 122.50% | 122.36% |